Viral Vaccines Market Size Estimated to Observe Significant Growth by 2031

Viral Vaccines Market: Introduction

Vaccines are biological preparations, generally produced from living organisms, which enhance immunity against a particular disease. Vaccines that prevent occurrence of a disease are called prophylactic vaccines and in some cases, those that treat diseases are called therapeutic vaccines.

Read Report Overview - https://www.transparencymarketresearch.com/viral-vaccines-market.html

A vaccine is usually made from a weakened or killed form of the disease-causing microorganism

  • Viral vaccines contain killed or attenuated virus or their product that can activate the immune system to produce antibodies against them. The five types of viral vaccines are: live whole viral vaccine, killed whole viral vaccine, subunit vaccine (purified or recombinant viral antigen), anti-idiotype antibodies, and DNA vaccine.
  • Live viral vaccines are prepared by reducing virulence of pathogen, but keeping it alive. Killed viral vaccine consist of virus particle grown on culture and subsequently killed by using heat or formaldehyde. Subunit vaccines (purified or recombinant viral antigen) are created by exposing viral particle in bacteria, yeast, or mammalian cell (an alternative application of recombinant DNA technology for production of hybrid virus vaccines). Anti-idiotype antibodies have the ability to mimic foreign antigen approach that leads to their development as vaccine in order to induce immunity against virus in experimental animals. DNA vaccination involves direct introduction of genetically engineered DNA so that cells directly produce an antigen.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45168

Key Drivers and Restraints of Global Viral Vaccines Market

  • Rise in prevalence of several infectious and non-infectious disease and technological advancements are projected to drive the global viral vaccines market during the forecast period
  • According to the World Health Organization (WHO), various disease vaccines are in pipeline and undergoing clinical trials. Rise in number of vaccines in pipeline is expected to propel the global viral vaccines market.
  • Additionally, a large number of vaccination programs, government and non-government initiatives, and an increase in the demand for combined vaccine boost the market
  • However, the cost associated with storage and transportation of vaccines and limited reimbursement coverage are projected to restrain the global viral vaccines market during the forecast period
  • Stringent government regulation for the approval of biological products is also likely to hamper the market in the next few years

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=45168

North America to Lead Global Viral Vaccines Market

  • In terms of region, the global viral vaccines market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • North America is expected to account for a notable share of the global market from 2020 to 2031, due to an increase in initiatives by the United States Department of Health and Human Services (HHS). This is a key factor that encourages immunization programs in the U.S.
  • Europe is expected to be the second-largest market for viral vaccines during the forecast period, due to a rise in prevalence of infectious diseases, government initiatives, and focused product development in the region
  • The viral vaccines market in Asia Pacific is expected to expand rapidly during the forecast period. Expansion of the market in the region is attributed to an increase in awareness about prevention of viral diseases, rapidly development of healthcare infrastructure, and a surge in adoption of technology in the region.

Pre Book Viral Vaccines Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=45168&ltype=S

  • Governments in Latin America and Middle East & Africa are taking initiatives in research & development of vaccines, which in turn is estimated to fuel the market in these regions at a moderate pace during the forecast period
  • Economic development in countries in Africa is considerably sluggish; hence, the market in the region is projected to expand at a low growth rate during the forecast period

Key Players Operating in Global Viral Vaccines Market

Key players operating in the global viral vaccines market are:

  • Seqirus (CSL Limited)
  • Merck & Co., Inc.
  • AstraZeneca plc
  • Emergent BioSolutions Inc.
  • Novartis, Inc.
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Sanofi
  • Serum institute of India Private Limited
  • Novavax, Inc.

Browse more Reports by Transparency Market Research: 

Blood Glucose Test Strips Market: Rise in prevalence of diabetes and high awareness for continuous glucose monitoring in order to control diabetes are likely to drive the global blood glucose test strips market from 2018 to 2026.

Tissue Banking Market: Surge in government initiatives to promote better facilities, increase in strategic collaborations along with mergers and acquisitions, and rise in applications of human tissue are expected to drive the global tissue banking market.

Pharmaceutical Waste Management Market: Increase in awareness about safe disposal of pharmaceuticals and environmental conservation, and rapidly increasing patient population are likely to fuel the global pharmaceutical waste management market from 2018 to 2026.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Back to news